These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1. Schlievert PM Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743 [TBL] [Abstract][Full Text] [Related]
4. Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest. Tierno PM; Hanna BA Rev Infect Dis; 1989; 11 Suppl 1():S182-6; discussion S186-7. PubMed ID: 2928635 [TBL] [Abstract][Full Text] [Related]
5. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918 [TBL] [Abstract][Full Text] [Related]
6. Effects of toxic shock syndrome Staphylococcus aureus, endotoxin and tampons in a mouse model. Tierno PM; Malloy V; Matias JR; Hanna BA Clin Invest Med; 1987 Mar; 10(2):64-70. PubMed ID: 3581548 [TBL] [Abstract][Full Text] [Related]
7. Toxic shock syndrome. Heap MG; Tagg JR N Z Med J; 1987 Mar; 100(820):169-71. PubMed ID: 3452034 [No Abstract] [Full Text] [Related]
8. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection. Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722 [TBL] [Abstract][Full Text] [Related]
9. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. Lee AC; Crass BA; Bergdoll MS J Clin Microbiol; 1987 Jan; 25(1):87-90. PubMed ID: 3793877 [TBL] [Abstract][Full Text] [Related]
13. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Bonventre PF; Heeg H; Cullen C; Lian CJ Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600 [TBL] [Abstract][Full Text] [Related]
14. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production. Schlievert PM; Blomster DA; Kelly JA Obstet Gynecol; 1984 Nov; 64(5):666-71. PubMed ID: 6436761 [TBL] [Abstract][Full Text] [Related]
15. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus restricted to endogenous air in tampons. Reiser RF; Hinzman SJ; Bergdoll MS J Clin Microbiol; 1987 Aug; 25(8):1450-2. PubMed ID: 3624443 [TBL] [Abstract][Full Text] [Related]
16. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins. Schlievert PM J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303 [TBL] [Abstract][Full Text] [Related]
17. Effect of the Today contraceptive sponge on growth and toxic shock syndrome toxin-1 production by Staphylococcus aureus. Remington KM; Buller RS; Kelly JR Obstet Gynecol; 1987 Apr; 69(4):563-9. PubMed ID: 3822297 [TBL] [Abstract][Full Text] [Related]
18. [A case of toxic shock syndrome from which TSST producing Staphylococcus aureus was isolated from a tampon and vaginal fluid]. Ishihara T; Yanase Y; Igarashi H Kansenshogaku Zasshi; 1987 May; 61(5):619-23. PubMed ID: 3117949 [No Abstract] [Full Text] [Related]